AM

Ayush Malhotra

Active Director Director DIN 09079518
DIN 09079518 First appointment Feb 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Ayush Malhotra

Data last updated:

Ayush Malhotra is a Director at Sayone Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Sayone Pharmaceuticals Private Limited reported revenue of ₹33,945 (FY 2022).

DIN 09079518
Primary Designation Director
Industry Healthcare
First Appointment 24 Feb 2021
Oldest Company Age 7 yrs
Largest company Sayone Pharmaceuticals Private Limited · ₹33,945 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Feb 20212019₹33,945 (FY 2022)Active

Board colleagues of Ayush Malhotra

NameDINCompanyDesignation
Ronak Barala08594448Sayone Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sayone Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ayush Malhotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayush Malhotra

Ayush Malhotra currently holds 1 directorship: Sayone Pharmaceuticals Private Limited (Director, since 24 Feb 2021, revenue ₹33,945 (FY 2022)).

Ayush Malhotra was first appointed on 24 Feb 2021 as Director at Sayone Pharmaceuticals Private Limited.

The current boards of Ayush Malhotra's companies include Ronak Barala (Sayone Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available